41.34
price down icon2.18%   -0.92
after-market Dopo l'orario di chiusura: 41.34
loading

Revolution Medicines Inc Azioni (RVMD) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
100.00%
-
0.742 - 3.824 7.014
Operating Expenses
22.06%
140.86
180.72 123.25 112.62 82.17
Operating Income/Loss
21.74%
-140.86
-179.98 -123.25 -108.80 -75.16
Nonoperating Income/Loss
32.29%
24.86
18.79 10.95 10.50 7.059
Income/Loss From Continuing Operations Before Tax
28.04%
-116.00
-161.19 -112.30 -98.30 -68.10
Income Tax Expense/Benefit
100.00%
-
0.343 -3.867 - -
Income/Loss From Continuing Operations After Tax
28.19%
-116.00
-161.54 -108.43 -98.30 -68.10
Net Income/Loss
28.19%
-116.00
-161.54 -108.43 -98.30 -68.10
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,644%
164.73
9.4474 109.23 106.88 94.83
Diluted Average Shares
1,644%
164.73
9.4474 109.23 106.88 94.83
Basic Earnings Per Share
42.15%
-0.70
-1.21 -0.99 -0.92 -0.72
Diluted Earnings Per Share
42.15%
-0.70
-1.21 -0.99 -0.92 -0.72
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
Capitalizzazione:     |  Volume (24 ore):